Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Thymosin Alpha-1 An immune-modulating peptide approved as a pharmaceutical product in more than 30 countries for applications including hepatitis B, hepatitis C, and immune adjuvant therapy in oncology
While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds
Massage thoroughly until absorbed and rotate application sites to ensure even coverage and prevent skin sensitivity
This commonly includes lifelong treatment for pernicious anaemia, managing severe B12 deficiency with neurological symptoms to prevent further damage, and for individuals post-gastric surgery due to impaired absorption
TB 500 and inflammation-related signaling pathways A study conducted by researchers [10] examined potential support that thymosin beta 4 may provide to inflammation-associated molecular signaling pathways
The pivotal mouse study used subcutaneous injection, not oral dosing a real mismatch between the tested route and typical community/commercial use
